A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain cancer known for its rapid growth and insensitivity to typical treatments. Studies are constantly underway to identify new management strategies, and recently, a new biomarker named LCA168 has emerged as a potential focus for GBM treatment. LCA168 is a protein that is highly expressed in glioblastoma cells compar